Skip to main content
Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
15.13
-0.68 (-4.30%)
At close: Nov 13, 2026, 4:00 PM EST
15.22
+0.08 (0.56%)
After-hours: Nov 13, 2026, 4:10 PM EST

Attovia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Net Income
-78.87-60.63-39.8
Depreciation & Amortization
0.970.80.31
Other Amortization
-0.39-
Loss (Gain) From Sale of Assets
-0.010.01
Loss (Gain) From Sale of Investments
-1.04-2.66-0.68
Stock-Based Compensation
3.692.391.39
Other Operating Activities
0.60.222.2
Change in Accounts Payable
1.410.181.72
Change in Other Net Operating Assets
-4.70.1-0.18
Operating Cash Flow
-77.95-59.2-35.04
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Capital Expenditures
-0.43-2.31-1.77
Investment in Securities
-162.22-71.14-38.03
Investing Cash Flow
-162.65-73.46-39.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Long-Term Debt Repaid
---0.17
Net Debt Issued (Repaid)
0.45--0.17
Issuance of Common Stock
309.450.190.31
Other Financing Activities
-3.71-0.38-0.02
Financing Cash Flow
306.19142.0182.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Net Cash Flow
65.69.367.91

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Free Cash Flow
-78.38-61.51-36.81
Free Cash Flow Growth
---
Free Cash Flow Margin
-5442.78%-4556.44%-
Free Cash Flow Per Share
-7.44-15.57-10.42
Levered Free Cash Flow
--40.21-
Unlevered Free Cash Flow
--40.21-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Change in Working Capital
-3.290.281.54
SEC Filings: 10-K · 10-Q